期刊文献+

骨桥蛋白在直肠癌中的蛋白水平表达研究 被引量:2

Protein expression study on osteopontin of rectal cancer
暂未订购
导出
摘要 目的:探讨骨桥蛋白(OPN)在直肠癌中的蛋白水平表达的临床意义。方法:采用免疫组织化学两步法对80例直肠癌组织中的OPN表达进行检测。结果:OPN在直肠癌组织中的阳性表达率为60%,其中Dukes′A、B期患者和Dukes′C、D期患者分别为31.1%和80%(P<0.01);淋巴结转移组和无淋巴结转移组分别为72.4%和33.3%(P<0.01);肝转移组和无肝转移组阳性表达率分别为76.9%和41.8%(P<0.05)。Kaplan-Meier分析,OPN阳性表达者的生存时间和5年生存率显著低于OPN阴性表达者(P<0.01)。结论:OPN的表达与直肠癌的进展和转移关系密切,对判断预后具有重要意义。 Objective:To explore the clinical significance of osteopontin (OPN) protein expression in rectal cancer.Methods:The expression of OPN of 80 cases of rectal cancer were studied with immunohistoehemical two steps technique.Results:The expressive rate of OPN of rectal cancer was 60%.The expression of Dukes' A-B grade and of Dukes'C-D grade were 31.1% and 80% respectively (P〈0.01).The expression of lymph node metastasis and of no lymph node metastasis were 72.4% and 33.3%, respectively(P〈0.01).The expression of liver metastasis and of no liver metastasis were 76.9% and 41.8%,respectively (P〈0.05).The mean survival time and 5-year survival rate in cases with positive OPN expression were significantly shorter than that of cases with negative expression(P〈0.01).Condusion:The expression of OPN was closely related to the development of rectal cancer ,and would be a valuable prognostic marker.
出处 《中日友好医院学报》 2007年第6期349-351,F0003,共4页 Journal of China-Japan Friendship Hospital
关键词 直肠癌 骨桥蛋白 免疫组织化学 预后 rectal cancer osteopontin immunohistochemistry prognosis
  • 相关文献

参考文献10

  • 1Lauwaet T,Oliveira MJ,Mareel M,et al.Molecular mechanisms of invasion by cancer cells,leukocytes and microorganisms [J].Microbes and Infection, 2000,2(8) : 923-931.
  • 2许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1380
  • 3Weber G F. The metastasis gene osteopontin:a candidate target for cancer therapy [J].Biochim Biophys Acta,2001,1552 (2) :61-85.
  • 4Crosby AH,Edwards SJ,Murray JC,et al.Genomic organization of the human osteopontin gene:exclusion of the locus from a causative role in the pathogenesis of dentinogenesis imperfecta type Ⅱ [J].Genomics, 1995,27 ( 1 ) : 155-160.
  • 5Furger KA,Menon RK,Tuckl AB et al. The functional and clinical roles of osteopontin in cancer and metastasis[J].Curr Mol Med 2001,1:621-632.
  • 6Tuck AB,Elliott BE,Hota C et al.Osteopontin-induced,integrindependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met)[J].J Cell Biochem,2000,78:465-475.
  • 7Tuck AB,Hota C,Chambers AF.Osteopontin (OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase(uPA)-dependent[J].Breast Cancer Res Treat,2001, 70:197-204.
  • 8Denhardt DT, Noda M,O'Regan AW,et al.Osteopontin as a means to cope with environmental insults:Regulation of inflammation,tissue remodeling,and cell survival [J].J Clin Invest,2001,107:1055-1061.
  • 9Shanahan CM, Weissberg PL, Metealfe JC.Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells[J].Circ Res,1993,73:193-204.
  • 10Yeatman TJ, Chambers AF. Osteopontin and colon cancer progression[J].Clin Exp Metastasis,2003,20(1):85-90.

二级参考文献3

共引文献1379

同被引文献21

  • 1Rittling SR, Chambers AF. Role of osteopontin in tumour progres- sion [ J]. Br J Cancer,2004,90 (10) : 1877-1881.
  • 2Kurisetty VV, Johnston PG, Rudland PS, et al. Identification of genes differentially expressed between benign and osteopontin transformed rat mammary epithelial cells[ J]. BMC Res Notes ,2009,2:15.
  • 3Courter D, Cao H, Kwok S, et al. The RGD domain of human os- teopontin promotes tumor growth and metastasis through activation of survival pathways[ J]. PLoS One ,2010,5 ( 3 ) : e9633.
  • 4Harada N, Mizoi T, Kinouchi M, et al. Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells[ J]. Int J Cancer,2001,91 (1) :67-75.
  • 5Senger DR, Wirth DF, Hynes RO. Transtbrmed mammalian cells secrete specific proteins and phosphoproteins [ J ]. Cell, 1979, 16 (4) :885-893.
  • 6Lee JL, Wang MJ, Sudhir PR, et al. Osteopontin promotes inte- grin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal canc- er cells [ J ]. Cancer Res,2007,67 ( 5 ):2089-2097.
  • 7Zhang YG, Zhang SJ. Research progress on the relationship be- tween osteopontin and hepatic eehinococeosis [ J ], Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi,2011,29(4) : 310-313, 318.
  • 8Dai J, Peng L, Fan K, et al. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells [ J]. Oncogene ,2009,28 (38) :3412-3422.
  • 9Chakraborty G, Jain S, Kundu GC. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and anglo- genesis via autocrine and paracrine mechanisms [ J ]. Cancer Res, 2008,68( 1 ) :152-161.
  • 10Das R, Philip S, Mahabeleshwar GH, et al. Osteopontin: it' s role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type ptasminogen activator expression [ J ]. IUBMB Life, 2005,57(6) :441-447.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部